Skip to main content

Eteplirsen Side Effects

Medically reviewed by Last updated on Aug 3, 2023.

Applies to eteplirsen: intravenous solution.

Serious side effects of Eteplirsen

Along with its needed effects, eteplirsen may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking eteplirsen:

More common

Other side effects of Eteplirsen

Some side effects of eteplirsen may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

For Healthcare Professionals

Applies to eteplirsen: intravenous solution.


The most commonly reported adverse events were balance disorder and vomiting.[Ref]


Postmarketing reports: Flushing[Ref]


Very common (10% or more): Contact dermatitis (25%), rash, urticaria[Ref]


Very common (10% or more): Vomiting (38%)[Ref]


Frequency not reported: Hypersensitivity reactions[Ref]


Very common (10% or more): Catheter site pain

Postmarketing reports: Cyanosis of the lips[Ref]


Postmarketing reports: Dehydration[Ref]

Nervous system

Very common (10% or more): Balance disorder (38%), headache[Ref]


Very common (10% or more): Cough

Postmarketing reports: Bronchospasm[Ref]


Postmarketing reports: Malaise, pyrexia, protein urine present[Ref]

Frequently asked questions


1. (2016) "Product Information. Exondys 51 (eteplirsen)." Sarepta Therapeutics

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.